Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Hospital Care for COVID-19 on the Prevalence of Multidrug-resistant Microorganisms Among Patients Compared to Non-COVID-19 Hospital Care in Limited-resource Hospitals in Indonesia

NCT05293483 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT05293483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Hospital Care for COVID-19 on the Prevalence of Multidrug-resistant Microorganisms Among Patients Compared to Non-COVID-19 Hospital Care in Limited-resource Hospitals in Indonesia
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Unknown status
Start date
March 7, 2022
Completion date
March 7, 2023
Enrollment
1,110 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant infection, covid-19